ES345040A2 - New peptides having an acth-activity - Google Patents

New peptides having an acth-activity

Info

Publication number
ES345040A2
ES345040A2 ES345040A ES345040A ES345040A2 ES 345040 A2 ES345040 A2 ES 345040A2 ES 345040 A ES345040 A ES 345040A ES 345040 A ES345040 A ES 345040A ES 345040 A2 ES345040 A2 ES 345040A2
Authority
ES
Spain
Prior art keywords
boc
lys
val
gly
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES345040A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES345040A2 publication Critical patent/ES345040A2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Abstract

Novel peptides which differ from an ACTH- peptide with 18-39 aminoacid residues and an N-terminal L-amino acid in that they contain as N-terminal the residue of D-serine, as the 3rd amino acid glyane and as the 17th and 18th aminoacids L-lysine are prepared by methods known in the peptide art. Intermediates isolated are BOC-D-ser-Fyr-glymet - glu(OtBu) - his - phe - arg - Fry - gly- OH BOC D - ser - Fyr - gly - met - glu(OtBu)- his - phe - arg - Fry - gly - lys (BOC) - pro - valgly - [lys(BOC)] 4 - NH 2 Z - or H - val - Fyrpro - NH 2 Z - or H - lys(BOC) - val - tyr - pro- NH 2 Z- or H-val-lys(BOC)-val-Fyr-pro-NH2 Z- or H-[lys(BOC)]2-pro-val-lys(BOC)-val-Fyrpro-NH 2 Z- or H-lys(BOC).pro-val-gly-[lys- (BOC] 4 - pro - val - lys(BOC) - val - Fyr - pro- NH 2 BOC- or H-tyr-gly-OCH 3 BOC-D-ser- Fyr-gly-OCH 3 or -OH BOC-D-ser-tyr-gly-nle- OCH 3 or -NHNH 2 BOC-D-ser-Fyr-gly-nleglu(OtBu) - his - phe - arg - Fry - gly - OH and BOC - D - ser - Fyr - gly - nle - glu(OtBu) - hisphe - arg - Fry - gly - lys(BOC) - pro - val - [lys- (BOC)] 4 - pro - val - lys(BOC) - val - tyr - pro- OtBu. Pharmaceutical compositions having adrenocorticotropic activity comprise one of the novel peptides together with a suitable carrier for enteral or parenteral application.
ES345040A 1966-09-16 1967-09-14 New peptides having an acth-activity Expired ES345040A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1343066 1966-09-16
CH1452666A CH529103A (en) 1966-09-16 1966-10-07 Process for the production of new peptides with ACTH effects
CH80467 1967-01-19

Publications (1)

Publication Number Publication Date
ES345040A2 true ES345040A2 (en) 1968-11-01

Family

ID=27172427

Family Applications (1)

Application Number Title Priority Date Filing Date
ES345040A Expired ES345040A2 (en) 1966-09-16 1967-09-14 New peptides having an acth-activity

Country Status (10)

Country Link
JP (1) JPS49183B1 (en)
AT (1) AT317448B (en)
BE (1) BE703945A (en)
CH (1) CH529103A (en)
DE (1) DE1643274B2 (en)
ES (1) ES345040A2 (en)
FR (1) FR7816M (en)
GB (1) GB1203301A (en)
NL (1) NL143552B (en)
SE (1) SE359822B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5072774U (en) * 1973-11-10 1975-06-26

Also Published As

Publication number Publication date
SE359822B (en) 1973-09-10
DE1643274B2 (en) 1976-07-22
DE1643274A1 (en) 1971-07-29
NL6712664A (en) 1968-03-18
NL143552B (en) 1974-10-15
FR7816M (en) 1970-05-20
GB1203301A (en) 1970-08-26
BE703945A (en) 1968-03-15
CH529103A (en) 1972-10-15
JPS49183B1 (en) 1974-01-05
AT317448B (en) 1974-08-26

Similar Documents

Publication Publication Date Title
SE8101585L (en) NUTRITION COMPOSITION, AS WELL AS ITS ADMINISTRATION
GB1498048A (en) Decapeptide amides
DE3066654D1 (en) Acyl peptides and pharmaceutical preparations thereof, as well as their manufacture and use
DE68927379T2 (en) SLIDE BLOCKING PEPTIDES
AU472647B2 (en) N-protected amino acids and peptides
JPS5594934A (en) Peptide type polymer and pharmaceutic composition containing it
ES345040A2 (en) New peptides having an acth-activity
MX167236B (en) SYNTHETIC PEPTIDES OF THYMOSINE -1 AND METHOD FOR OBTAINING THEM
GB1309150A (en) Acthactive peptides and process for their manufacture
ES434673A1 (en) Solid phase synthesis of ACTH
GB1536878A (en) Octapeptide
GR3017297T3 (en) Novel substrate peptides.
ES316390A1 (en) Peptides having an adrenocorticotropic hormone action and process for their manufacture
GB1342803A (en) Psychopharmacological preparation
ES418158A1 (en) Peptides of acth activity containing alpha-aminooxy carboxylic acids on both terminals and a process for the preparation thereof
GB1437477A (en) Synthetic peptides
GB1298318A (en) Corticotropin peptides
GB1353827A (en) Acthaction peptides and process for their manufacture
GB1287125A (en) New peptides and process for their manufacture
GB992957A (en) New decapeptides and their manufacture
GB1516725A (en) Polypeptides having acth-like action
GB1231494A (en)
ES421641A1 (en) Procedure for the preparation of a biologically active peptide of the human parathyroid hormone. (Machine-translation by Google Translate, not legally binding)
GB1210551A (en) New peptides having an acth-activity and process for their manufacture
ES417951A1 (en) Peptides of ACTH activity containing {60 -aminooxy carboxylic acid on the N-terminal moiety, and a process for the preparation thereof